enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Nivolumab - Wikipedia

   en.wikipedia.org/wiki/Nivolumab

   Nivolumab, sold under the brand name Opdivo, is an anti-cancer medication used to treat a number of types of cancer. [2] This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal ...

3. PD-1 and PD-L1 inhibitors - Wikipedia

   en.wikipedia.org/wiki/PD-1_and_PD-L1_inhibitors

   Nivolumab (Opdivo) was developed by Bristol-Myers Squibb and first approved by the FDA in 2014 for the treatment of melanoma. It was later approved for squamous cell lung cancer, renal cell carcinoma, and Hodgkin's lymphoma.

4. US FDA approves Bristol-Myers' lung cancer drug

   www.aol.com/news/us-fda-approves-bristol-myers...

   The drug, to be sold under the brand name Augtyro, is set to compete in a crowded market for lung cancer treatments that includes Bristol Myers' other cancer treatment Opdivo and rival cancer ...

5. Bristol-Myers releases mixed Opdivo lung cancer results

   www.aol.com/news/bristol-myers-releases-mixed...

   The U.S. drugmaker said that Opdivo combined with chemotherapy failed to extend overall survival more than chemotherapy alone in patients with advanced non-squamous non-small cell lung cancer (NSCLC).

6. Programmed cell death protein 1 - Wikipedia

   en.wikipedia.org/wiki/Programmed_cell_death...

   A number of cancer immunotherapy agents that target the PD-1 receptor have been developed. One such anti-PD-1 antibody drug, nivolumab, (Opdivo - Bristol Myers Squibb), produced complete or partial responses in non-small-cell lung cancer, melanoma, and renal-cell cancer, in a clinical trial with a total of 296 patients. [39]

7. Bristol Myers' injectable form of Opdivo meets main goal in ...

   www.aol.com/news/bristol-myers-injectable-form...

   Opdivo is currently approved in more than 65 countries for various forms of cancer either as the only drug or in combination with other medicines. The company recorded $4.35 billion in Opdivo ...

8. Treatment of lung cancer - Wikipedia

   en.wikipedia.org/wiki/Treatment_of_lung_cancer

   Treatment of lung cancer. Treatment of lung cancer refers to the use of medical therapies, such as surgery, radiation, chemotherapy, immunotherapy, percutaneous ablation, and palliative care, [1][2][3][4] alone or in combination, in an attempt to cure or lessen the adverse impact of malignant neoplasms originating in lung tissue.

9. Bristol Myers' Opdivo extends survival in bladder cancer study

   www.aol.com/news/bristol-myers-bladder-cancer...

   Opdivo was being studied in patients with types of urothelial carcinoma, or bladder cancer, who are eligible for standard-of-care cisplatin-based chemotherapy. Bristol Myers' Opdivo extends ...